This week’s edition broadens the lens slightly. Australian small caps still offer some of the market’s most interesting opportunities, particularly where execution is starting to match the narrative, but offshore markets are becoming harder to ignore as AI enthusiasm, semiconductor demand, and resilient earnings continue supporting selective U.S. growth names.
The mix this week includes a fast-growing Australian healthcare company, a speculative technology business with genuine milestones approaching, and one of the most closely watched semiconductor companies in global markets. They are completely different businesses, but all three share one important trait, investors now have visible. . .
Gain full access to all our premium investment intelligence
Plans from $9.99 per week, cancel anytime.
Subscribe or upgrade to Full Stock Picks to view this content